Vertex Pharmaceuticals Ownership | Who Owns Vertex Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Vertex Pharmaceuticals Ownership Summary


Vertex Pharmaceuticals is owned by 17.34% institutional investors, 0.18% insiders, and 82.48% retail investors. Capital world investors is the largest institutional shareholder, holding 9.98% of VRTX shares. Capital Group Growth Fnd of Amer Comp is the top mutual fund, with 5.11% of its assets in Vertex Pharmaceuticals shares.

VRTX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockVertex Pharmaceuticals17.34%0.18%82.48%
SectorHealthcare Stocks 232.64%10.66%-143.30%
IndustryBiotech Stocks 382.13%10.41%-292.54%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Capital world investors25.51M9.98%$11.57B
Vanguard group24.11M9.43%$10.93B
Blackrock funding, inc. /de23.75M9.29%$10.77B
Blackrock21.31M8.25%$9.99B
Capital research global investors17.32M6.77%$7.85B
State street11.61M4.52%$4.55B
Jpmorgan chase6.04M2.36%$2.74B
Geode capital management5.98M2.34%$2.70B
Wellington management group llp4.77M1.86%$1.87B
Capital investors4.73M1.85%$2.15B

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Kynam capital management, lp330.00K11.93%$154.68M
Provident investment management149.26K6.16%$67.67M
Montchanin asset management10.74K4.76%$5.03M
Andrew hill investment advisors12.41K4.28%$5.63M
Bellevue group505.81K4.12%$198.09M
Bridger management18.78K3.96%$7.35M
Artia global partners lp55.10K3.42%$21.58M
Healthinvest partners ab22.98K3.32%$10.42M
Mcrae capital management35.56K3.29%$16.12M
Sectoral asset management8.01K2.91%$3.63M

Top Buyers

HolderShares% AssetsChange
Norges bank3.18M0.15%3.18M
Blackrock funding, inc. /de23.75M0.18%1.50M
Winslow capital management887.64K1.36%887.64K
Capital research global investors17.32M1.45%763.06K
Squarepoint ops607.84K0.24%432.15K

Top Sellers

HolderShares% AssetsChange
Fmr3.30M0.07%-3.10M
Parnassus investments---1.65M
Artisan partners limited partnership---650.26K
Blackrock21.31M0.23%-648.44K
Edgewood management1.06M2.29%-427.47K

New Positions

HolderShares% AssetsChangeValue
Norges bank3.18M0.15%3.18M$1.44B
Winslow capital management887.64K1.36%887.64K$405.10M
Rakuten investment management242.46K0.09%242.46K$24.14M
Axa investment managers163.68K0.17%163.68K$64.10M
Sofinnova investments117.88K2.52%117.88K$46.16M

Sold Out

HolderChange
Cgc financial services-1.00
Mine & arao wealth creation & management, llc.-1.00
Mcclarren financial advisors-1.00
Ruedi wealth management-1.00
Perkins coie trust-1.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 2025806-48.63%44,328,589-80.90%170.21%410-40.58%269-56.19%
Sep 30, 2025865-46.24%59,581,660-75.23%230.26%362-50.82%356-41.54%
Jun 30, 20251,575-5.06%240,147,0121.70%931.11%716-14.86%5994.90%
Mar 31, 20251,6401.74%235,693,425-0.06%911.09%82911.42%567-7.35%
Dec 31, 20241,444-9.69%218,148,736-5.74%841.05%664-9.78%543-5.89%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Capital Group Growth Fnd of Amer Comp12.98M5.11%487.71K
American Funds Growth Fund of Amer A12.98M5.11%487.71K
Vanguard US Total Market Shares ETF8.18M3.19%16.09K
Vanguard Total Stock Mkt Idx Inv7.99M3.15%17.16K
Vanguard Institutional 500 Index Trust7.30M2.84%51.91K
Vanguard 500 Index Investor6.46M2.54%40.26K
Capital Group Investment Co of Amer Comp5.44M2.14%-
American Funds Invmt Co of Amer A5.44M2.14%-
Invesco QQQ Trust5.43M2.14%-12.04K
American Funds American Balanced A4.62M1.82%129.23K

Recent Insider Transactions


DateNameRoleActivityValue
Mar 13, 2026Bozic Carmen EVP and CMOSell$1.12M
Mar 11, 2026McKechnie Duncan EVP, Chief Commercial OfficerSell$1.31M
Mar 04, 2026McKechnie Duncan EVP, Chief Commercial OfficerSell$1.16M
Mar 02, 2026Liu Joy EVP and Chief Legal OfficerSell$442.40K
Feb 27, 2026Kewalramani Reshma CEO & PresidentSell$191.90K

Insider Transactions Trends


DateBuySell
2026 Q1-54
2025 Q4-23
2025 Q341
2025 Q2-2
2025 Q1-21

VRTX Ownership FAQ


Who Owns Vertex Pharmaceuticals?

Vertex Pharmaceuticals shareholders are primarily institutional investors at 17.34%, followed by 0.18% insiders and 82.48% retail investors. The average institutional ownership in Vertex Pharmaceuticals's industry, Biotech Stocks , is 382.13%, which Vertex Pharmaceuticals falls below.

Who owns the most shares of Vertex Pharmaceuticals?

Vertex Pharmaceuticals’s largest shareholders are Capital world investors (25.51M shares, 9.98%), Vanguard group (24.11M shares, 9.43%), and Blackrock funding, inc. /de (23.75M shares, 9.29%). Together, they hold 28.70% of Vertex Pharmaceuticals’s total shares outstanding.

Does Blackrock own Vertex Pharmaceuticals?

Yes, BlackRock owns 8.25% of Vertex Pharmaceuticals, totaling 21.31M shares as of Jun 2024. This represents 0.23% of BlackRock's total assets, with a market value of 9.99B$. In the last quarter, BlackRock decreased its holdings by -648K shares, a -2.95% change.

Who is Vertex Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Kynam capital management, lp is Vertex Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 11.93% of its assets in 330K Vertex Pharmaceuticals shares, valued at 154.68M$.

Who is the top mutual fund holder of Vertex Pharmaceuticals shares?

Capital Group Growth Fnd of Amer Comp is the top mutual fund holder of Vertex Pharmaceuticals shares, with 5.11% of its total shares outstanding invested in 12.98M Vertex Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools